Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.

× No keyword cloud information.

37 in total

Review 1. Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors: J Lilleyman
Journal: Paediatr Drugs Date: 1999 Jul-Sep Impact factor: 3.022

Review 2. Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

Authors: Stacey L Berg; Marc C Chamberlain
Journal: Curr Oncol Rep Date: 2003-01 Impact factor: 5.075

3. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Authors: Joanne Kurtzberg; Barbara Asselin; Mark Bernstein; George R Buchanan; Brad H Pollock; Bruce M Camitta
Journal: J Pediatr Hematol Oncol Date: 2011-12 Impact factor: 1.289

Review 4. Asparagine synthetase chemotherapy.

Authors: Nigel G J Richards; Michael S Kilberg
Journal: Annu Rev Biochem Date: 2006 Impact factor: 23.643

Review 5. Current options for the treatment of neoplastic meningitis.

Authors: Ilkcan Cokgor; Allan H Friedman; Henry S Friedman
Journal: J Neurooncol Date: 2002-10 Impact factor: 4.130

6. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

Authors: A M Aslanian; B S Fletcher; M S Kilberg
Journal: Biochem J Date: 2001-07-01 Impact factor: 3.857

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.

Review 1. Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Review 2. Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

3. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).

Review 4. Asparagine synthetase chemotherapy.

Review 5. Current options for the treatment of neoplastic meningitis.

6. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

Review 7. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.

Review 8. Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

9. A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

10. Parathyroid necrosis and hypocalcemic tetany induced in rabbits by L-asparaginase.